Scholars Central

CommentaryPublished 11 Aug 2016

PSMA PET/CT imaging and therapy

Authors: levent kabasakal, Emre Demirci

Imaging in Medicine

Volume 7 · Issue 2

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Prostate-specific membrane antigen (PSMA) is increasingly recognized as a novel target for the PET imaging of prostate cancer (PCa) and 68Ga-DKFZ-11 (68Ga-PSMA) has been suggested as a novel tracer for detection of PCa relapses and metastasis. First human studies of PSMA PET/CT imaging have demonstrated high tracer uptake at the sites of primary tumor and lymph node and bone metastasis in direct correlation with aggressiveness and Gleason scores. PSMA PET/ CT seems to be a highly accurate imaging tool for restaging of prostate cancer patients with biochemical recurrence. PSMA PET/CT imaging may be used in order to develop a treatment strategy for recurrent disease even in patients with low PSA levels. As a theranostic approach its counterpart Lu-177 labelled ligands have a potential role for the treatment of castration resistant prostate cancer.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Imaging in Medicine.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalImaging in Medicine
  • SubjectRadiology & Imaging
  • BylineArticles whose byline prints “levent kabasakal”
  • BylineArticles whose byline prints “Emre Demirci”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels